Saroja Pharma Industries India Ltd
SAROJASaroja Pharma Industries India Ltd
SAROJA
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.40 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.72 | 6.72 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Saroja Pharma Industries India is actively involved in trading pharmaceutical active pharmaceutical ingredients (API), pharma intermediates, and chemicals used in human and veterinary medicines, including specialty chemical imports and exports.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 36.75 | 55.95 | 50.35 | 40.86 | — | |||||
Raw Materials | 33.73 | 50.13 | 48.70 | 32.17 | — | |||||
| Power & Fuel Cost | 0.00 | 0.01 | 0.03 | 0.03 | ||||||
| Employee Cost | 0.55 | 0.73 | 0.83 | 0.92 | ||||||
| Selling & Administrative Expenses | 1.44 | 2.39 | 1.15 | 1.27 | ||||||
| Operating & Other expenses | -0.36 | 0.27 | -3.23 | 3.72 | ||||||
EBITDA | 1.39 | 2.42 | 2.87 | 2.75 | — | |||||
| Depreciation/Amortization | 0.02 | 0.05 | 0.07 | 0.09 | — | |||||
| PBIT | 1.37 | 2.37 | 2.80 | 2.66 | — | |||||
| Interest & Other Items | 0.33 | 0.80 | 1.32 | 1.45 | — | |||||
| PBT | 1.04 | 1.57 | 1.48 | 1.21 | — | |||||
| Taxes & Other Items | 0.30 | 0.44 | 0.43 | 0.33 | — | |||||
| Net Income | 0.74 | 1.13 | 1.05 | 0.88 | — | |||||
| EPS | 740.00 | 95.83 | 6.64 | 2.53 | — | |||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Saroja Pharma Industries India Ltd | 23.30 | 1.40 | — |
| Sun Pharmaceutical Industries Ltd | 46.63 | 6.65 | 0.73% |
| Cipla Ltd | 29.52 | 4.54 | 0.86% |
| Mankind Pharma Ltd | 61.94 | 12.37 | — |
Price Comparison
Compare SAROJA with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Sep 2023
Mar 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
SAROJA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSaroja Pharma Industries India will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
Saroja Pharma Industries India announced that the 6th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant